EU conditionally clears IMS Health's acquisition of parts of Cegedim
MLex Summary: The European Commission has cleared IMS Health's purchase of assets from Cegedim, a company involved in market research for the pharmaceuticals industry. The clearance was granted on condition that...To view the full article, register now.
Already a subscriber? Click here to view full article